--
Related Articles
Research
Research Alert: Idexx Posts Solid Q1 Fueled By Innovation And Strong Cag Group Performance
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:IDEXX posted strong Q1 results with EPS of $3.47 (+17% Y/Y), beating expectations by $0.06, while revenue reached $1.141B (+14% Y/Y), $30M above consensus. CAG Diagnostics recurring revenue grew 14% Y/Y to $920M, demonstrating resilient demand for core diagnostic solutions. Operating margin expanded 10 bps to 31.8%, supported by strong recurring revenue gains and operational productivity initiatives. International markets showed particular strength with CAG revenue growing 22.7% compared to 11% domestically, highlighting successful global expansion efforts, in our view. The 12% expansion in the global premium instrument installed base and 20% growth in VetLab consumables underscore continued innovation adoption. Management raised the full-year 2026 guidance, reflecting confidence in the business trajectory, in our view: IDXX sees 2026 sales in the range of $4.675B-4.760B vs. prior $4.632B-$4.720B, representing +8.6%-10.6% Y/Y growth and EPS of $14.45-$14.90 vs. prior $14.29-$14.80, reflecting +11%-14% Y/Y.
$IDXX
Research
Pason Systems Upgraded to Buy at TD
Pason Systems Inc. (PSI.TO) was upgraded to Buy from Hold at TD Securities on Tuesday.Analyst Aaron MacNeil increased his price target on shares of the Calgary-based provider of instrumentation and data management systems for drilling rigs to $18 from $13 ahead of its Q1 results on May 7."Our Energy Services coverage is at a positive inflection point amid strong commodity prices, although many stocks have already re-rated," MacNeil said in a note to clients."However, Pason has lagged despite its many positive attributes, including its high barriers to entry, strong operating leverage, low sustaining CapEx commitments, low debt and attractive yield," the analyst said."This disconnect drives our upgrade to Buy."
$PSI.TO
Research
Research Alert: Fisv Q1: Transformation Costs Mount As Growth And Margins Deteriorate
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FISV delivered challenging Q1 results with adjusted EPS of $1.79 (-16% Y/Y, beating by $0.21) on revenue of $4.68B (-2% Y/Y, missing by $50M). Organic revenue declined 4%, while adjusted operating margin compressed 810 bps to 29.7% during the "One Fiserv" transformation. We think Q1 reinforced that FISV remains in a difficult transition period where transformation investments weigh on near-term profitability while growth benefits have yet to materialize. Management emphasized early-stage execution, with CEO noting results aligned with February expectations, as the company incurred $142M in transformation expenses. Both segments showed weakness: Merchant Solutions achieved flat revenue but -1% organic decline with 780bps margin compression to 26.4%, while Financial Solutions revenue fell 5% (-6% organic) with margins down 940bps to 38.1%. We believe the May 14th Investor Day will be critical for providing visibility on when "One Fiserv" investments will generate meaningful returns to justify current challenges.
$FISV